More recently, Sabha et al. compared CD147-CAR-T and CD147-CAR-NK cells in the human CD147 knock-in HCC model and found that CAR-NK cells maintained high antitumor efficacy with minimal toxicity to CD147+ healthy tissues and reduced neuroinflammation compared to CAR-T cells. This evidence concerns the gene BSG and hepatocellular carcinoma.